Jing Xu
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Sun Yat-sen University(CN)Shanxi Medical University(CN)Yangtze University(CN)Dalian Medical University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Sichuan University(CN)Fudan University(CN)Peking Union Medical College Hospital(CN)Wuhan University(CN)West China Hospital of Sichuan University(CN)Sun Yat-sen Memorial Hospital(CN)Second Affiliated Hospital of Dalian Medical University(CN)Renmin Hospital of Wuhan University(CN)Institute of Hematology & Blood Diseases Hospital(CN)Fu Wai Hospital(CN)
Publications by Year
Research Areas
Metabolomics and Mass Spectrometry Studies, Cardiovascular Function and Risk Factors, Cardiac Imaging and Diagnostics, Advanced MRI Techniques and Applications, Heavy Metal Exposure and Toxicity
Most-Cited Works
- → Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage(2017)484 cited
- → Spatially resolved metabolomics to discover tumor-associated metabolic alterations(2018)361 cited
- → SIRT1 Suppresses Activator Protein-1 Transcriptional Activity and Cyclooxygenase-2 Expression in Macrophages(2009)209 cited
- → MRI T1 Mapping in Hypertrophic Cardiomyopathy: Evaluation in Patients Without Late Gadolinium Enhancement and Hemodynamic Obstruction(2019)133 cited
- → Global and Targeted Metabolomics of Esophageal Squamous Cell Carcinoma Discovers Potential Diagnostic and Therapeutic Biomarkers(2013)123 cited
- → Overexpression of SIRT1 in vascular smooth muscle cells attenuates angiotensin II-induced vascular remodeling and hypertension in mice(2013)123 cited